Study directory

Mental health studies with practical context.

Public study records, presented in a clearer and more patient-friendly format for mental health research discovery.

Back to overview
23847studies shown
Showing 13,333-13,344 of 23,847
Drug study icon
CompletedEUCTR 2004-004009-10

Efficacy of agomelatine (25 mg/day with potential adjustment to 50 mg) given orally on rest/activity circadian rhythms in outpatients with Major Depressive Disorder. A inte...

This study is completed in Germany, in Austria, in Italy, .... It focuses on depression.

In Germany
DepressionOther
Countries
Germany, Austria, Italy, ...
Sponsor
Institut de Recherches Internationales Servier [...] 1. Institut de Recherches Internationales Servier 2. Laboratorios Servier S.L. (For Spain only)
Condition
Depression
Drug study icon
CompletedEUCTR 2005-002388-95

Efficacy of agomelatine (25 to 50 mg/day) given orally on quality of remission in elderly depressed patients, after a 12-week treatment period.A flexible-dose internationa...

This study is completed in Belgium, in Hungary, in Denmark, .... It focuses on Depression.

In Hungary
DepressionOther
Countries
Belgium, Hungary, Denmark, ...
Sponsor
Institut de Recherches Internationales Servier [...] 1. Institut de Recherches Internationales Servier 2. Laboratorios Servier S.L. (For Spain only)
Condition
Depression
Drug study icon
CompletedNCT01108393

Efficacy of Agomelatine in people with OCD

This summary needs review. Please check the official study record and contact the research team for details.

In Tel Litwinsky
OCDDrugFrom 18 Years to 65 Years
Countries
Israel
Sponsor
Institut de Recherches Internationales Servier
Condition
OCD
Drug study icon
CompletedNCT00560079

Efficacy of Allopurinol and Dypiridamole in Acute Mania

This study exists to compare options and see whether a digital app or remote support tool offers something meaningfully different. Researchers are trying to understand whether a digital app or remote support tool can give earlier or clearer feedback during care.

In Porto Alegre
BipolarityDrugFrom 18 Years to 65 Years
Countries
Brazil
Sponsor
Hospital Espirita de Porto Alegre
Condition
Bipolarity
Behavioral study icon
CompletedNCT02481895

Efficacy of an Innovative E-neurocognitive Module for Bipolarity

This study exists to explore whether a digital app or remote support tool could improve care and understanding. Researchers are trying to understand whether a digital app or remote support tool can improve attention, thinking, or day-to-day functioning.

In Barcelona
BipolarityBehavioralFrom 18 Years to 60 Years
Countries
Spain
Sponsor
Consorcio Centro de Investigación Biomédica en Red (CIBER)
Condition
Bipolarity
Behavioral study icon
CompletedNCT06186570

Efficacy of an Online-Based Self-Help Intervention for Auditory Hallucinations in Persons With Psychotic Disorders

This study exists to see whether a guided support group can make care clearer and more responsive. Researchers are trying to understand whether a guided support group can improve attention, thinking, or day-to-day functioning.

In Berlin
SchizophreniaBehavioralFrom 18 Years to 75 Years
Countries
Germany
Sponsor
Charite University, Berlin, Germany
Condition
Schizophrenia
Behavioral study icon
CompletedNCT02150668

Efficacy of an Organizational Skills Intervention for Middle School Students With ADHD

This study exists to understand how a medication treatment holds up over time after the earliest research stage. Researchers are trying to understand whether a medication treatment can improve attention, thinking, or day-to-day functioning.

In Richmond
ADHDBehavioralFrom 11 Years to 15 Years
Countries
United States
Sponsor
Virginia Commonwealth University
Condition
ADHD
Data coverage

Public registry coverage is progressing

HopeStage gathers information about mental health clinical trials from the public registries we currently index. We are progressively improving registry coverage, but this does not mean that every study in the world is already included.